These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 22224596

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.
    Verrijckt A, Proulx F, Morneau S, Vobecky S.
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1812-3. PubMed ID: 15173742
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Low-dose recombinant factor VIIa in the management of uncontrolled postoperative hemorrhage in cardiac surgery patients.
    van de Garde EM, Bras LJ, Heijmen RH, Knibbe CA, van Dongen EP, Wiltink EH, Biesma DH.
    J Cardiothorac Vasc Anesth; 2006 Aug; 20(4):573-5. PubMed ID: 16884993
    [No Abstract] [Full Text] [Related]

  • 29. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
    Hoffmann T, Assmann A, Dierksen A, Roussel E, Ullrich S, Lichtenberg A, Albert A, Sixt S.
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
    Hollis AL, Lowery AV, Pajoumand M, Pham SM, Slejko JF, Tanaka KA, Mazzeffi M.
    Ann Card Anaesth; 2016 Oct; 19(3):418-24. PubMed ID: 27397445
    [Abstract] [Full Text] [Related]

  • 34. Recombinant activated factor VII in cardiac surgery: single-center experience.
    Singh SP, Chauhan S, Choudhury M, Malik V, Choudhary SK.
    Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Gielen-Wijffels SE, van Mook WN, Ramsay G.
    Ned Tijdschr Geneeskd; 2003 Mar 01; 147(9):419. PubMed ID: 12661464
    [No Abstract] [Full Text] [Related]

  • 37. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
    von Heymann C, Spies C, Grubitzsch H, Schönfeld H, Sander M, Volk T.
    Hamostaseologie; 2006 Aug 01; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
    [Abstract] [Full Text] [Related]

  • 38. Invited commentary.
    Welsby IJ, Ortel TL.
    Ann Thorac Surg; 2007 Jul 01; 84(1):168-9. PubMed ID: 17588405
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.